174 related articles for article (PubMed ID: 16181654)
1. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.
Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A
Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654
[TBL] [Abstract][Full Text] [Related]
2. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
Nègre D; Mangeot PE; Duisit G; Blanchard S; Vidalain PO; Leissner P; Winter AJ; Rabourdin-Combe C; Mehtali M; Moullier P; Darlix JL; Cosset FL
Gene Ther; 2000 Oct; 7(19):1613-23. PubMed ID: 11083469
[TBL] [Abstract][Full Text] [Related]
5. Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene.
Mergia A
Virology; 1994 Feb; 199(1):219-22. PubMed ID: 8116246
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
8. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
9. The simian immunodeficiency virus (SIV) rev gene regulates env expression.
Cheng SM; Blume M; Lee SG; Hung PP; Hirsch VM; Johnson PR
J Med Primatol; 1990; 19(3-4):167-76. PubMed ID: 2231681
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
[TBL] [Abstract][Full Text] [Related]
11. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
12. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).
Herchenröder O; Renne R; Loncar D; Cobb EK; Murthy KK; Schneider J; Mergia A; Luciw PA
Virology; 1994 Jun; 201(2):187-99. PubMed ID: 8184531
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
14. Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3).
Renne R; Mergia A; Renshaw-Gegg LW; Neumann-Haefelin D; Luciw PA
Virology; 1993 Jan; 192(1):365-9. PubMed ID: 8390763
[TBL] [Abstract][Full Text] [Related]
15. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
17. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A
Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857
[TBL] [Abstract][Full Text] [Related]
18. Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation.
Grunwald T; Pedersen FS; Wagner R; Uberla K
J Gene Med; 2004 Feb; 6(2):147-54. PubMed ID: 14978768
[TBL] [Abstract][Full Text] [Related]
19. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
[TBL] [Abstract][Full Text] [Related]
20. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
